What liver side effects are reported with Vascepa (icosapent ethyl)?
Vascepa (icosapent ethyl) can affect the liver in some patients. The main liver-related adverse effects clinicians monitor for are elevated liver enzymes, which show up on blood tests as increased ALT, AST, or similar markers. These lab changes can be noticed even when a patient does not feel symptoms.
What symptoms could suggest a liver problem?
If a liver issue were to occur, the symptoms patients often associate with liver problems include jaundice (yellowing of the skin or eyes), dark urine, unusual fatigue, abdominal pain (especially right-sided upper belly pain), nausea, and loss of appetite. If any of these occur while taking Vascepa, medical evaluation is warranted.
How common are liver enzyme elevations or liver injury?
The amount of detail on frequency is not provided in the information available here. In practice, liver-related monitoring is important because triglyceride-lowering and omega-3–type medicines can be associated with changes on liver function tests in a subset of users, and clinicians typically check labs when indicated by symptoms or risk factors.
Who might be at higher risk?
People with existing liver disease or abnormal baseline liver tests are the ones clinicians are most likely to watch closely. Risk can also be influenced by other medications that affect the liver and by alcohol use.
What should patients do if their liver tests rise?
If liver enzymes rise, clinicians typically decide between (1) repeating labs to confirm the change, (2) adjusting other medications that could be contributing, or (3) stopping Vascepa if a more significant pattern of liver injury is suspected. The right action depends on the size of the lab elevation, whether symptoms are present, and how quickly the values change.
Do I need liver blood tests while taking Vascepa?
If you have a history of liver disease or previously abnormal liver tests, your clinician may order periodic liver function tests. If you develop symptoms suggestive of liver problems, liver labs are generally evaluated as part of the work-up.
Sources
No sources were provided in the prompt, and I don’t have access to additional document text here to cite specific prescribing-label statements about Vascepa liver adverse events.